Research Insight
Abraxane for the Treatment of Late-Stage Pancreatic Cancer, United States of America
Abraxane (albumin-bound paclitaxel for injectable suspension) is an intravenous injection indicated for the treatment of metastatic pancreatic cancer. The drug was originally developed by...
News
UF Health successfully implements genomic medicine program
GAINESVILLE, Fla. — At the conclusion of the first year of UF Health’s Personalized Medicine Program, the results are in: The program has successfully...
Research Insight
Drug to fight leukemia in sight, say Australian researchers
After discovering a potential molecular "target" for leukemia, Australian researchers say a drug to fight the disease is "in their sights," although it is...
Research Insight
Zonegran (Zonisamide) for the Treatment of Epilepsy, Switzerland
Zonegran (Zonisamide) is an anti-epileptic drug indicated for the treatment of partial seizures in adults with epilepsy with or without secondary generalisation. ...
Research Insight
Cetilistat – Investigational Drug for Obesity, Japan
Developed by Alizyme, a specialist biopharmaceutical company in collaboration with Takeda Pharmaceutical, cetilistat (ATL-962) is an experimental treatment for obesity. Cetilistat restricts pancreatic lipases...
Press Releases
Biovision speakers will debate economic and business challenges in the life sciences market
Top industry players, European Commission representatives, the WHO, the Innovative Medicine Initiative, the European Institute of Innovation and Technology and Chinese delegations will participate...
Techno Trends
Xenometrix – Mutagenicity Assays and Cytotoxicity Screening Kits
Xenometrix produces and distributes today's most advanced mutagenicity assays and cytotoxicity screening kits designed to help reduce hands-on time, test compound consumption, plastic waste...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read